Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase - Concepedia

Concepedia

Publication | Open Access

Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase

DOI Full Paper Access

27

Citations

1

References

2013

Year

Deborah S. Mortensen, John Sapienza, Branden G.S. Lee, Sophie Perrin-Ninkovic, Roy Harris, Graziella Shevlin, Jason S. Parnes, Brandon Whitefield, Matthew Hickman, Gody Khambatta,

Bioorganic & Medicinal Chemistry Letters

Signal TransductionSignaling PathwayMolecular PathwayMedicineReceptor Tyrosine KinaseSelective InhibitorMtor KinaseCore ModificationPharmacologyCell BiologyCell SignalingNovel TherapyDrug Discovery

References

	Year	Citations

Page 1

Page 1